Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Betamethasone Dipropionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 8 EU WC, 2 KDMF, 10 NDC API, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

143 FDF Dossiers, 79 FDA Orange Book, 7 Europe, 3 Canada, 24 Australia, 9 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Actylis, 1 Alcedo Pharmachem, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 1 Kerry, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical, 13 Film Formers & Plasticizers, 9 Emulsifying Agents, 7 Solubilizers, 6 Lubricants & Glidants, 6 Thickeners and Stabilizers, 6 Parenteral, 5 Fillers, Diluents & Binders, 5 Coating Systems & Additives, 4 Taste Masking, 4 Controlled & Modified Release, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Granulation, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Co-Processed Excipients

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 17 Finished Drug Prices, 9 Annual Reports

MARKET PLACE

18 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents

20 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 5 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
26/09/2024	Curia	U.S.A	Curia Spain S. A. U.	219MF10367	Betamethasone dipropionate (JP)	2007-12-13	2017-12-08	Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain
26/09/2024	MSD INTL GMBH	Singapore	MSD International GmbH (Singapore Branch)	218MF10865	Betamethasone dipropionate	2006-11-06	2014-03-13	50 Tuas West Drive Singapore 638408

Betamethasone Dipropionate

Betamethasone Dipropionate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers

16 USDMF

8 CEP/COS

6 JDMF

8 EU WC

2 KDMF

10 NDC API

32 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

143 FDF Dossiers

79 FDA Orange Book

7 Europe

3 Canada

24 Australia

9 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE

CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 0.05% BASE

OINTMENT;TOPICAL - EQ 0.05% BASE

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

2 SPI Pharma

3 DKSH

1 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Actylis

1 Alcedo Pharmachem

11 BASF

1 Clariant

4 Corel Pharma Chem

2 Finar

1 Kerry

4 Lubrizol Life Science Health

11 Roquette

1 Seppic

2 Shandong Focus Biotechnology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical

13 Film Formers & Plasticizers

9 Emulsifying Agents

7 Solubilizers

6 Lubricants & Glidants

6 Thickeners and Stabilizers

6 Parenteral

5 Fillers, Diluents & Binders

5 Coating Systems & Additives

4 Taste Masking

4 Controlled & Modified Release

3 Direct Compression

3 Surfactant & Foaming Agents

2 Granulation

2 Chewable & Orodispersible Aids

1 Soft Gelatin

1 Rheology Modifiers

1 Co-Processed Excipients

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

17 Finished Drug Prices

CREAM;TOPICAL - EQ 0.05% BASE;1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons